Therefore, the WAO/EAACI international guideline for the management of hereditary angioedema recommends that patients suspected of having HAE who have normal C1-INH levels and function should be screened for known mutations underlying HAE-nC1-INH (15). The gene discussed is COL18A1; the disease is hereditary angioedema.